Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
Multiplex Assay Kit for Caveolin 1 (CAV1) ,etc. by FLIA (Flow Luminescence Immunoassay)
VIP21; Caveolae Protein 22kDa
(Note: Up to 8-plex in one testing reaction)
- Product No.LMA214Ra
- Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
- Sample TypeSerum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3.5h
- Detection Range0.01-10ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.003 ng/mL.
- DownloadInstruction Manual
- UOM 8Plex 7Plex 6Plex 5Plex 4Plex 3Plex 2Plex1Plex
- FOB
US$ 427
US$ 443
US$ 468
US$ 501
US$ 534
US$ 583
US$ 657
Result
For more details, please contact local distributors! US$ 821 Add to Price Calculator
Specificity
This assay has high sensitivity and excellent specificity for detection of Caveolin 1 (CAV1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Caveolin 1 (CAV1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Caveolin 1 (CAV1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Caveolin 1 (CAV1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 84-93 | 89 |
EDTA plasma(n=5) | 90-104 | 97 |
heparin plasma(n=5) | 96-104 | 99 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Caveolin 1 (CAV1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Caveolin 1 (CAV1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Caveolin 1 (CAV1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 81-102% | 78-96% | 79-95% | 89-99% |
EDTA plasma(n=5) | 80-88% | 89-96% | 88-96% | 84-101% |
heparin plasma(n=5) | 78-101% | 97-105% | 81-101% | 83-104% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
96-well plate | 1 | Plate sealer for 96 wells | 4 |
Pre-Mixed Standard | 2 | Standard Diluent | 1×20mL |
Pre-Mixed Magnetic beads (22#:CAV1) | 1 | Analysis buffer | 1×20mL |
Pre-Mixed Detection Reagent A | 1×120μL | Assay Diluent A | 1×12mL |
Detection Reagent B (PE-SA) | 1×120μL | Assay Diluent B | 1×12mL |
Sheath Fluid | 1×10mL | Wash Buffer (30 × concentrate) | 1×20mL |
Instruction manual | 1 |
Assay procedure summary
1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Mendel Net | Novel prostate cancer tumour markers in a cell line model Mendelu: source |
Oncology reports | Caveolin-1 as a potential high-risk prostate cancer biomarker PubMed: 22159333 |
Anticancer Research | Increased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese men Pubmed: 23645736 |
Sarcoidosis Vasc Diffuse Lung Dis.? | Decrased sputum caveolin-1 is associated with systemic sclerosis related lung disease Pubmed:24751454 |
Cancer Genomics and Proteomics | Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression PubMed: 26543085 |
Atherosclerosis | Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction Pubmed:26775120 |
Arthritis Research & Therapy | Increased caveolin-1 in intervertebral disc degeneration facilitates repair Pubmed:26939667 |
Oxid Med Cell Longev | Lower Serum Caveolin-1 Is Associated with Cerebral Microbleeds in Patients with Acute Ischemic Stroke Pubmed:27119011 |
Inflammation | Caveolin-1 Promotes the Imbalance of Th17/Treg in Patients with Chronic Obstructive PulmonaryDisease. pubmed:27613621 |
Oxidative Medicine and Cellular Longevity | Swim Training Modulates Skeletal Muscle Energy Metabolism, Oxidative Stress, and Mitochondrial Cholesterol Content in Amyotrophic Lateral Sclerosis Mice Pubmed:29849903 |
Microcirculation | Endothelium‐dependent hyperpolarization‐mediated vasodilatation compensates nitric oxide‐mediated endothelial dysfunction during ischemia in diabetes‐induced … Pubmed:29665152 |
Genetic Testing and Molecular Biomarkers | The CAV1 Gene 3′ Untranslated Region Single Nucleotide Polymorphisms Are Associated with the Risk of Pulmonary Hypertension in Chinese Han Chronic … |
Cell Rep | SIRT6 transcriptionally regulates fatty acid transport by suppressing PPAR¦Ã 34077730 |
researchsquare | Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of Rt-PA?¡ |
Molecules | 5, 2′-Dibromo-2, 4′, 5′-trihydroxydiphenylmethanone Inhibits LPS-Induced Vascular Inflammation by Targeting the Cav1 Protein Pubmed:35566232 |
Catalog No. | Related products for research use of Rattus norvegicus (Rat) Organism species | Applications (RESEARCH USE ONLY!) |
RPA214Ra01 | Recombinant Caveolin 1 (CAV1) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA214Ra01 | Polyclonal Antibody to Caveolin 1 (CAV1) | WB; IHC; ICC; IP. |
LAA214Ra71 | Biotin-Linked Polyclonal Antibody to Caveolin 1 (CAV1) | WB; IHC; ICC. |
MAA214Ra21 | Monoclonal Antibody to Caveolin 1 (CAV1) | WB; IHC; ICC; IP. |
SEA214Ra | ELISA Kit for Caveolin 1 (CAV1) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA214Ra | Multiplex Assay Kit for Caveolin 1 (CAV1) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |